Human Factor IX (Factor 9) AssayMax ELISA Kit (WHO Standard Calibrated Controls Included)

This assay employs a quantitative enzyme immunoassay technique that measures the specified antigen in samples.

Cat# Size Price Qty Buy
EF1009-7 96 Well Plate £320.94

Additional Information

Property Value or Rating
Manufacturer Assaypro, LLC.
Product Type AssayMax™ ELISA Kits
Samples Serum, Cell Culture, CSF
Species Human
Reactivity Human
Assay Format Sandwich ELISA
Product Size 96 Well Plate
Range 1.56-100 ng/ml
Plex Number 1
Storage Refer to component labels for details
Entrez Gene 2158
Omim 300746
UniProt P00740
UniGene Hs.522798
Special Notes For Research Use Only, Not To Be Used For Diagnostic Purposes
References * Dadehbeigi N et al. (2008) Sex hormones affect the production of recombinant Factor IX in CHO and HEK-293 cell lines. Biotechnol Lett. 30(11):1909-12 
* Fima UE et al. (2010) Long-Acting Coagulation Factors and Methods of Producing Same. Patent No: US 8476234 B2 
* Guild BC et al. (2012) Lipid nanoparticle compositions and methods for mrna delivery. Patent Application WO2012170930 A1
* Ostroff RM et al. (2012) Early detection of malignant pleural mesothelioma in asbestos-exposed individuals with a noninvasive proteomics-based surveillance tool. PLoS One. 7(10):e46091 
* Derosa F et al.(2014) Lipidic nanoparticles for mrna delivering. Patent application:WO2014089486 A1 
* Heartlein M (2014) Mrna therapeutic compositions and use to treat diseases and disorders. Patent application:WO2014152940 A1 

" title="

* Dadehbeigi N et al. (2008) Sex hormones affect the production of recombinant Factor IX in CHO and HEK-293 cell lines. Biotechnol Lett. 30(11):1909-12 
* Fima UE et al. (2010) Long-Acting Coagulation Factors and Methods of Producing Same. Patent No: US 8476234 B2 
* Guild BC et al. (2012) Lipid nanoparticle compositions and methods for mrna delivery. Patent Application WO2012170930 A1
* Ostroff RM et al. (2012) Early detection of malignant pleural mesothelioma in asbestos-exposed individuals with a noninvasive proteomics-based surveillance tool. PLoS One. 7(10):e46091 
* Derosa F et al.(2014) Lipidic nanoparticles for mrna delivering. Patent application:WO2014089486 A1 
* Heartlein M (2014) Mrna therapeutic compositions and use to treat diseases and disorders. Patent application:WO2014152940 A1 

" target="_blank">

* Dadehbeigi N et al. (2008) Sex hormones affect the production of recombinant Factor IX in CHO and HEK-293 cell lines. Biotechnol Lett. 30(11):1909-12 
* Fima UE et al. (2010) Long-Acting Coagulation Factors and Methods of Producing Same. Patent No: US 8476234 B2 
* Guild BC et al. (2012) Lipid nanoparticle compositions and methods for mrna delivery. Patent Application WO2012170930 A1
* Ostroff RM et al. (2012) Early detection of malignant pleural mesothelioma in asbestos-exposed individuals with a noninvasive proteomics-based surveillance tool. PLoS One. 7(10):e46091 
* Derosa F et al.(2014) Lipidic nanoparticles for mrna delivering. Patent application:WO2014089486 A1 
* Heartlein M (2014) Mrna therapeutic compositions and use to treat diseases and disorders. Patent application:WO2014152940 A1 

Related Documents